Symptom burden in cancer survivorship: insights from a survivorship program's patient-reported outcomes database.

内容摘要

This study aimed to examine the symptom burden reported by survivors treated in survivorship clinics by describing the severity of symptoms and symptom interference with life activities, comparing symptom severity by sex, and identifying predictors of the three most prevalent moderate to severe symptoms. This secondary data analysis examined patient-reported symptom burden data using the MD Anderson Symptom Inventory collected for clinical purposes from January to December 2023. Sex differences in symptom burden were compared using t-tests. Multivariate logistic regressions identified predictors of the three most prevalent moderate to severe symptoms. Among 2550 survivors (mean age 61.9&#x2009;&#xb1;&#x2009;12.1 years; 69.9% female, 36.4% breast cancer), the average time in survivorship care was 4.04&#x2009;&#xb1;&#x2009;4.00 years. Over 75% of survivors reported experiencing&#x2009;&#x2265;&#x2009;1 symptom, and 45% reported&#x2009;&#x2265;&#x2009;1 moderate-severe symptom. The three most prevalent moderate to severe symptoms were fatigue (25%), sleep disturbance (24%), and problems remembering (15%). Compared with males, females reported significantly more symptoms (p <&#x2009;0.05) and more moderate to severe symptoms (p <&#x2009;0.01). Female survivors and those under the age of 65 were more likely to report moderate to severe fatigue, sleep disturbance, and problems remembering (all p <&#x2009;0.01). The high prevalence of persistent symptoms among cancer survivors in this sample supports the need for routine symptom assessments in survivorship care. Age and sex are important considerations in tailoring supportive interventions. As the population of cancer survivors grows, understanding symptom burden across diagnoses is critical to inform effective supportive care strategies.